Encision INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Encision Inc., a medical device company specializing in patient safety technology for minimally invasive surgery, reported a significant reduction in net loss and an increase in gross profit for fiscal year 2025, driven by higher service revenue and improved product margins, despite a slight decrease in overall product revenue.
OTC.Pink
Encision Inc. reported a decrease in revenue for fiscal year 2024, while highlighting its commitment to expanding its patented Active Electrode Monitoring (AEM) technology.